DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer
Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expressi...
Saved in:
| Published in | PloS one Vol. 18; no. 5; p. e0284455 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
18.05.2023
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0284455 |
Cover
| Abstract | Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes.
A total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data.
The mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades.
This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. |
|---|---|
| AbstractList | Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes. A total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data. The mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades. This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. Background Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes. Materials and methods A total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data. Results The mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades. Conclusion This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes.BACKGROUNDBreast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes.A total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data.MATERIALS AND METHODSA total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data.The mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades.RESULTSThe mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades.This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC.CONCLUSIONThis study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes. A total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data. The mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades. This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. BackgroundBreast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes.Materials and methodsA total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data.ResultsThe mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades.ConclusionThis study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. Background Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA helicase family members. But, the relationship between clinicopathological, prognostic significance in different BC subtypes and DDX43 expression remains unclear. Therefore, the purpose of this study was to assess the clinicopathological significance of DDX43 protein and mRNA expression in different BC subtypes. Materials and methods A total of 80 females newly diagnosed with BC and 20 control females that were age-matched were recruited for this study. DDX43 protein levels were measured by ELISA technique. We used a real-time polymerase chain reaction quantification (real-time PCR) to measure the levels of DDX43 mRNA expression. Levels of DDX43 protein and mRNA expression within BC patients had been compared to those of control subjects and correlated with clinicopathological data. Results The mean normalized serum levels of DDX43 protein were slightly higher in control than in both benign and malignant groups, but this result was non-significant. The mean normalized level of DDX43 mRNA expression was higher in the control than in both benign and malignant cases, although the results were not statistically significant and marginally significant, respectively. Moreover, the mean normalized level of DDX43 mRNA expression was significantly higher in benign than in malignant cases. In malignant cases, low DDX43 protein expression was linked to higher nuclear grade and invasive duct carcinoma (IDC), whereas high mRNA expression was linked to the aggressive types of breast cancer such as TNBC, higher tumor and nuclear grades. Conclusion This study explored the potential of using blood DDX43 mRNA expression or protein levels, or both in clinical settings as a marker of disease progression in human breast cancer. DDX43 mRNA expression proposes a less invasive method for discriminating benign from malignant BC. |
| Audience | Academic |
| Author | Hammad, Amal M. Khairat, Rabab Kamel, Mahmoud M. Amer, Noha N. |
| AuthorAffiliation | 2 Medical Molecular Genetics Department, Human Genetics and Genomic Research Division, National Research Center, Cairo, Egypt 5 Baheya Centre for Early Detection and Treatment of Breast Cancer, Giza, Egypt 1 Faculty of Pharmacy (Girls), Department of Biochemistry and Molecular Biology, Al-Azhar University, Cairo, Egypt 3 Faculty of medicine, Department of Medical Biochemistry, Al-Azhar University, Damietta, Egypt 4 Clinical Pathology Department, National Cancer Institute, Cairo, Egypt Nelson Mandela African Institute of Science and Technology, UNITED REPUBLIC OF TANZANIA |
| AuthorAffiliation_xml | – name: 2 Medical Molecular Genetics Department, Human Genetics and Genomic Research Division, National Research Center, Cairo, Egypt – name: 5 Baheya Centre for Early Detection and Treatment of Breast Cancer, Giza, Egypt – name: 3 Faculty of medicine, Department of Medical Biochemistry, Al-Azhar University, Damietta, Egypt – name: 4 Clinical Pathology Department, National Cancer Institute, Cairo, Egypt – name: Nelson Mandela African Institute of Science and Technology, UNITED REPUBLIC OF TANZANIA – name: 1 Faculty of Pharmacy (Girls), Department of Biochemistry and Molecular Biology, Al-Azhar University, Cairo, Egypt |
| Author_xml | – sequence: 1 givenname: Noha N. orcidid: 0000-0002-7556-6434 surname: Amer fullname: Amer, Noha N. – sequence: 2 givenname: Rabab surname: Khairat fullname: Khairat, Rabab – sequence: 3 givenname: Amal M. surname: Hammad fullname: Hammad, Amal M. – sequence: 4 givenname: Mahmoud M. orcidid: 0000-0003-0264-3096 surname: Kamel fullname: Kamel, Mahmoud M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37200388$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11r2zAUhs3oWNts_2BshsHYLpJZlizLvRmh3UegrNB9sDuhyMeJiiJ5kly6fz85cUZcyhi-sDh63vdIr6TT5MhYA0nyHGUzhEv07sZ2zgg9a2N5luWMkKJ4lJygCudTmmf46GB8nJx6f5NlBWaUPkmOcZlnGWbsJKkvLn4SnG6uv8xTuGsdeK-sSYWp09bZAMqkGm5B-zSOHGgR-ulgU6mVUdK2Iqyttislhe4VjdKQ2iZdOhA-pFIYCe5p8rgR2sOz4T9Jvn_88O388_Ty6tPifH45lbTCYUoRZXlGIStIWTFa4CWpRFWXKGcoL5oSRORKUgKwWGTLvBR5xiqKcS0LJCieJC93vq22ng8BeR7lRY4pRVkkFjuituKGt05thPvNrVB8W7BuxYULSmrglcBkSWtKojGpWbOUTY1kBRUwIkpURq_3Q7duuYFagglO6JHpeMaoNV_ZW44yVJEK9-t9Mzg4-6sDH_hGeQlaCwO22y6clrQgcfWT5NU99OHtDdRKxB0o09jYWPamfF6SmF2B8r7t7AEqfjVs4pEa6A9xLHg7EkQmwF1Yic57vvh6_f_s1Y8x-_qAXYPQYe2t7vo75sfgi8Oo_2a8v8cRONsB0lnvHTRcqrC9q3FrSsfIef9o9qHx_tHw4dFEMbkn3vv_U_YH_FoZew |
| CitedBy_id | crossref_primary_10_1155_2024_9625043 crossref_primary_10_1371_journal_pone_0316591 crossref_primary_10_3390_genes15081065 |
| Cites_doi | 10.1074/jbc.RA120.015824 10.1007/BF02967488 10.1200/JCO.2010.29.5907 10.1016/j.ymeth.2022.03.002 10.1038/nrm.2016.50 10.14348/molcells.2017.2258 10.1002/cjp2.32 10.1245/s10434-010-0985-4 10.1126/sciadv.abd6991 10.1016/j.heliyon.2020.e03728 10.1016/j.ceca.2019.102078 10.1056/NEJMoa1813904 10.1073/pnas.1603992113 10.1158/2159-8290.CD-20-1647 10.1038/bjc.2014.168 10.1074/jbc.M117.774950 10.1517/13543776.2014.913025 10.1016/j.bbcan.2017.09.006 10.1136/jcp.2003.010777 10.5858/arpa.2019-0904-SA 10.1007/s10147-021-01892-1 10.1002/wrna.1163 10.1371/journal.pone.0134967 10.18632/oncotarget.7185 10.1038/s41419-023-05657-8 10.1093/nar/gky1131 10.1111/his.13498 10.3322/caac.21660 10.2217/fon-2021-0172 10.1016/j.bbrc.2019.09.114 10.5858/arpa.2013-0435-OA 10.1038/bjc.2014.120 10.1158/1535-7163.MCT-14-0095 10.5152/ejbh.2019.5004 10.1186/1756-0500-5-376 10.1016/j.genrep.2019.100463 10.1038/nprot.2008.73 10.1126/science.aax9198 10.1016/j.leukres.2014.02.012 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2023 Public Library of Science 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 Amer et al 2023 Amer et al 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Copyright: © 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2023 Public Library of Science – notice: 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 Amer et al 2023 Amer et al – notice: 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0284455 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Advanced Technologies & Aerospace Database ProQuest Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (Proquest) Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database (Proquest) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | DDX43 mRNA expression and protein levels in BC |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2815236610 oai_doaj_org_article_9a34b6d64a634d8fbcfd1c9e9e84a717 PMC10194936 A749745126 37200388 10_1371_journal_pone_0284455 |
| Genre | Journal Article |
| GeographicLocations | Egypt Canada United States United States--US |
| GeographicLocations_xml | – name: Egypt – name: Canada – name: United States – name: United States--US |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. ADRAZ BBORY CGR CUY CVF ECM EIF IPNFZ NPM RIG PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM AAPBV ABPTK N95 |
| ID | FETCH-LOGICAL-c693t-6168206e054798653b49a9d7128125f7eac69747ee8d718b27a2089633dc51a63 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Jul 02 11:03:55 EDT 2023 Wed Aug 27 01:15:24 EDT 2025 Thu Aug 21 18:36:59 EDT 2025 Fri Sep 05 09:27:09 EDT 2025 Fri Jul 25 10:36:36 EDT 2025 Tue Jun 17 21:32:22 EDT 2025 Tue Jun 10 20:49:33 EDT 2025 Fri Jun 27 05:44:03 EDT 2025 Fri Jun 27 06:03:18 EDT 2025 Thu May 22 20:47:13 EDT 2025 Wed Feb 19 01:58:34 EST 2025 Thu Apr 24 23:03:21 EDT 2025 Tue Jul 01 02:09:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | Copyright: © 2023 Amer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c693t-6168206e054798653b49a9d7128125f7eac69747ee8d718b27a2089633dc51a63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
| ORCID | 0000-0002-7556-6434 0000-0003-0264-3096 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0284455 |
| PMID | 37200388 |
| PQID | 2815236610 |
| PQPubID | 1436336 |
| PageCount | e0284455 |
| ParticipantIDs | plos_journals_2815236610 doaj_primary_oai_doaj_org_article_9a34b6d64a634d8fbcfd1c9e9e84a717 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10194936 proquest_miscellaneous_2816765452 proquest_journals_2815236610 gale_infotracmisc_A749745126 gale_infotracacademiconefile_A749745126 gale_incontextgauss_ISR_A749745126 gale_incontextgauss_IOV_A749745126 gale_healthsolutions_A749745126 pubmed_primary_37200388 crossref_citationtrail_10_1371_journal_pone_0284455 crossref_primary_10_1371_journal_pone_0284455 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-18 |
| PublicationDateYYYYMMDD | 2023-05-18 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2023 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | TD Schmittgen (pone.0284455.ref017) 2008; 3 H Wu (pone.0284455.ref045) 2019; 520 J Ferlay (pone.0284455.ref003) 2020 RS Singh (pone.0284455.ref048) 2022; 204 M Basu (pone.0284455.ref013) 2021; 7 KH Allison (pone.0284455.ref015) 2020; 144 PJ Van Diest (pone.0284455.ref031) 2004; 57 CF Bourgeois (pone.0284455.ref037) 2016; 17 J Lin (pone.0284455.ref044) 2014; 38 H Qayoom (pone.0284455.ref005) 2021; 17 SB Edge (pone.0284455.ref014) 2010; 17 A Raghavendra (pone.0284455.ref043) 2018; 73 MR Heerma van Voss (pone.0284455.ref009) 2017; 1868 M Uhlen (pone.0284455.ref023) 2019; 366 JY Wo (pone.0284455.ref030) 2011; 29 T Talwar (pone.0284455.ref022) 2017; 292 RS Singh (pone.0284455.ref011) 2022; 204 H Sung (pone.0284455.ref002) 2021; 71 Q Yang (pone.0284455.ref032) 2001; 8 EA Rakha (pone.0284455.ref019) 2014; 110 M Yanagawa (pone.0284455.ref016) 2012; 5 J Zhao (pone.0284455.ref042) 2019; 132 M Yadav (pone.0284455.ref010) 2021; 296 D Szklarczyk (pone.0284455.ref021) 2019; 47 MG Mathieu (pone.0284455.ref024) 2010; 10 AM Schwartz (pone.0284455.ref033) 2014; 138 E Maheswaran (pone.0284455.ref041) 2015; 10 F Robert (pone.0284455.ref027) 2013; 4 A Vinayagam (pone.0284455.ref040) 2016; 113 D Ye (pone.0284455.ref004) 2023; 14 M Oloomi (pone.0284455.ref036) 2020; 6 Y Kim (pone.0284455.ref046) 2016; 7 pone.0284455.ref018 TM Abdel-Fatah (pone.0284455.ref034) 2014; 110 P Aftimos (pone.0284455.ref007) 2021; 11 AR Green (pone.0284455.ref020) 2016; 2 G Ambrosini (pone.0284455.ref026) 2014; 13 M Wiese (pone.0284455.ref035) 2014; 24 W Zhang (pone.0284455.ref029) 2013; 6 M.A.M. Ali (pone.0284455.ref012) 2021; 26 N Duraker (pone.0284455.ref028) 2020; 16 N Safari-Alighiarloo (pone.0284455.ref039) 2014; 7 V Trapani (pone.0284455.ref038) 2019; 83 H Kim (pone.0284455.ref047) 2017; 40 MK Alkasaby (pone.0284455.ref001) 2020; 13 F André (pone.0284455.ref006) 2019; 380 H Salem (pone.0284455.ref008) 2019; 16 M Uhlen (pone.0284455.ref025) 2017; 357 39724251 - PLoS One. 2024 Dec 26;19(12):e0316591. doi: 10.1371/journal.pone.0316591 |
| References_xml | – volume: 296 start-page: 100085 year: 2021 ident: pone.0284455.ref010 article-title: The KH domain facilitates the substrate specificity and unwinding processivity of DDX43 helicase publication-title: J Biol Chem doi: 10.1074/jbc.RA120.015824 – volume: 8 start-page: 105 issue: 2 year: 2001 ident: pone.0284455.ref032 article-title: Correlation between nuclear grade and biological prognostic variables in invasive breast cancer publication-title: Breast Cancer doi: 10.1007/BF02967488 – volume: 29 start-page: 2619 issue: 19 year: 2011 ident: pone.0284455.ref030 article-title: Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2010.29.5907 – volume: 10 start-page: 2 year: 2010 ident: pone.0284455.ref024 article-title: DDX43, a cancer/testis antigen expressed at the protein level in a variety of cancers publication-title: Cancer Immun – volume: 357 issue: 6352 year: 2017 ident: pone.0284455.ref025 article-title: A pathology atlas of the human cancer transcriptome.Science. – volume: 204 start-page: 286 year: 2022 ident: pone.0284455.ref011 article-title: Structure-function analysis of DEAD-box helicase DDX43. publication-title: Methods doi: 10.1016/j.ymeth.2022.03.002 – volume: 204 start-page: 286 year: 2022 ident: pone.0284455.ref048 article-title: Structure-function analysis of DEAD-box helicase DDX43. publication-title: Methods. doi: 10.1016/j.ymeth.2022.03.002 – volume: 17 start-page: 426 issue: 7 year: 2016 ident: pone.0284455.ref037 article-title: The multiple functions of RNA helicases as drivers and regulators of gene expression publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2016.50 – volume: 13 start-page: 273 year: 2020 ident: pone.0284455.ref001 article-title: Polymorphism of XRCC3 in Egyptian Breast Cancer Patients. publication-title: Pharmgenomics Pers Med – volume: 40 start-page: 54 issue: 1 year: 2017 ident: pone.0284455.ref047 article-title: DDX53 Promotes Cancer Stem Cell-Like Properties and Autophagy publication-title: Mol Cells doi: 10.14348/molcells.2017.2258 – volume: 2 start-page: 32 issue: 1 year: 2016 ident: pone.0284455.ref020 article-title: Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. publication-title: J Pathol Clin Res doi: 10.1002/cjp2.32 – volume: 17 start-page: 1471 year: 2010 ident: pone.0284455.ref014 article-title: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-0985-4 – volume: 7 start-page: eabd6991 issue: 14 year: 2021 ident: pone.0284455.ref013 article-title: Predicting tissue-specific gene expression from whole blood transcriptome publication-title: Sci Adv doi: 10.1126/sciadv.abd6991 – year: 2020 ident: pone.0284455.ref003 article-title: Global Cancer Observatory: Cancer Today. publication-title: Lyon, France: International Agency for Research on Cancer. – volume: 6 start-page: e03728 issue: 4 year: 2020 ident: pone.0284455.ref036 article-title: Comparing blood versus tissue-based biomarkers expression in breast cancer patients publication-title: Heliyon doi: 10.1016/j.heliyon.2020.e03728 – volume: 83 start-page: 102078 year: 2019 ident: pone.0284455.ref038 article-title: Dysregulation of Mg2+ homeostasis contributes to acquisition of cancer hallmarks publication-title: Cell Calcium doi: 10.1016/j.ceca.2019.102078 – volume: 380 start-page: 1929 issue: 20 year: 2019 ident: pone.0284455.ref006 article-title: Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1813904 – volume: 113 start-page: 4976 issue: 18 year: 2016 ident: pone.0284455.ref040 article-title: Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1603992113 – volume: 11 start-page: 2796 issue: 11 year: 2021 ident: pone.0284455.ref007 article-title: Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-20-1647 – volume: 110 start-page: 2450 issue: 10 year: 2014 ident: pone.0284455.ref034 article-title: DDX43 (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. publication-title: Br J Cancer doi: 10.1038/bjc.2014.168 – volume: 292 start-page: 10429 issue: 25 year: 2017 ident: pone.0284455.ref022 article-title: The DEAD-box protein DDX43 (DDX43) is a dual RNA-DNA helicase and has a K-homology domain required for full nucleic acid unwinding activity. publication-title: J Biol Chem doi: 10.1074/jbc.M117.774950 – volume: 24 start-page: 723 issue: 6 year: 2014 ident: pone.0284455.ref035 article-title: DDX43, the helicase antigen as a biomarker for breast cancer prognosis (WO2013144616). publication-title: Expert Opin Ther Pat. doi: 10.1517/13543776.2014.913025 – volume: 1868 start-page: 510 issue: 2 year: 2017 ident: pone.0284455.ref009 article-title: Targeting RNA helicases in cancer: The translation trap publication-title: Biochim Biophys Acta Rev Cancer doi: 10.1016/j.bbcan.2017.09.006 – volume: 57 start-page: 675 issue: 7 year: 2004 ident: pone.0284455.ref031 article-title: Prognostic value of proliferation in invasive breast cancer: a review publication-title: J Clin Pathol doi: 10.1136/jcp.2003.010777 – volume: 144 start-page: 545 year: 2020 ident: pone.0284455.ref015 article-title: Estrogen and progesterone receptor testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists guideline update publication-title: Arch Pathol Lab Med doi: 10.5858/arpa.2019-0904-SA – volume: 26 start-page: 795 year: 2021 ident: pone.0284455.ref012 article-title: The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis publication-title: Int J Clin Oncol doi: 10.1007/s10147-021-01892-1 – volume: 132 start-page: jcs218628 issue: 1 year: 2019 ident: pone.0284455.ref042 article-title: MAGEA1 inhibits the expression of BORIS via increased promoter methylation publication-title: J Cell Sci – volume: 4 start-page: 333 issue: 4 year: 2013 ident: pone.0284455.ref027 article-title: Perturbations of RNA helicases in cancer. publication-title: Wiley Interdiscip Rev RNA doi: 10.1002/wrna.1163 – volume: 6 start-page: 445 issue: 3 year: 2013 ident: pone.0284455.ref029 article-title: Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified. publication-title: Int J Clin Exp Pathol – volume: 10 start-page: e0134967 issue: 8 year: 2015 ident: pone.0284455.ref041 article-title: Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer. publication-title: PLoS One doi: 10.1371/journal.pone.0134967 – volume: 7 start-page: 10297 issue: 9 year: 2016 ident: pone.0284455.ref046 article-title: miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2. publication-title: Oncotarget. doi: 10.18632/oncotarget.7185 – volume: 14 start-page: 106 issue: 2 year: 2023 ident: pone.0284455.ref004 article-title: DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP. publication-title: Cell Death Dis doi: 10.1038/s41419-023-05657-8 – volume: 47 start-page: D607 year: 2019 ident: pone.0284455.ref021 article-title: STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets publication-title: Nucleic Acids Res doi: 10.1093/nar/gky1131 – volume: 7 start-page: 17 issue: 1 year: 2014 ident: pone.0284455.ref039 article-title: Protein-protein interaction networks (PPI) and complex diseases. publication-title: Gastroenterol Hepatol Bed Bench. – volume: 73 start-page: 68 issue: 1 year: 2018 ident: pone.0284455.ref043 article-title: Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers publication-title: Histopathology doi: 10.1111/his.13498 – volume: 71 start-page: 209 issue: 3 year: 2021 ident: pone.0284455.ref002 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. publication-title: CA Cancer J Clin. doi: 10.3322/caac.21660 – volume: 17 start-page: 4185 issue: 31 year: 2021 ident: pone.0284455.ref005 article-title: An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer publication-title: Future Oncol doi: 10.2217/fon-2021-0172 – volume: 520 start-page: 594 issue: 3 year: 2019 ident: pone.0284455.ref045 article-title: DDX43 prefers single strand substrate and its full binding activity requires physical connection of all domains publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2019.09.114 – ident: pone.0284455.ref018 – volume: 138 start-page: 1048 issue: 8 year: 2014 ident: pone.0284455.ref033 article-title: Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program publication-title: Arch Pathol Lab Med doi: 10.5858/arpa.2013-0435-OA – volume: 110 start-page: 1688 issue: 7 year: 2014 ident: pone.0284455.ref019 article-title: Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. publication-title: Br J Cancer doi: 10.1038/bjc.2014.120 – volume: 13 start-page: 2073 issue: 8 year: 2014 ident: pone.0284455.ref026 article-title: Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-14-0095 – volume: 16 start-page: 22 issue: 1 year: 2020 ident: pone.0284455.ref028 article-title: A Comparison of the Clinicopathological Features, Metastasis Sites and Survival Outcomes of Invasive Lobular, Invasive Ductal and Mixed Invasive Ductal and Lobular Breast Carcinoma. publication-title: Eur J Breast Health. doi: 10.5152/ejbh.2019.5004 – volume: 5 start-page: 376 year: 2012 ident: pone.0284455.ref016 article-title: Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype. publication-title: BMC Res Notes doi: 10.1186/1756-0500-5-376 – volume: 16 start-page: 100463 year: 2019 ident: pone.0284455.ref008 article-title: APOA1 and APOA2 proteins as prognostic markers for early detection of urinary bladder cancer publication-title: Gene Reports doi: 10.1016/j.genrep.2019.100463 – volume: 3 start-page: 1101 issue: 6 year: 2008 ident: pone.0284455.ref017 article-title: Analyzing real-time PCR data by the comparative C(T) method. publication-title: Nat Protoc. doi: 10.1038/nprot.2008.73 – volume: 366 start-page: eaax issue: 6472 year: 2019 ident: pone.0284455.ref023 article-title: A genome-wide transcriptomic analysis of protein-coding genes in human blood cells publication-title: Science doi: 10.1126/science.aax9198 – volume: 38 start-page: 601 issue: 5 year: 2014 ident: pone.0284455.ref044 article-title: DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia publication-title: Leuk Res doi: 10.1016/j.leukres.2014.02.012 – reference: 39724251 - PLoS One. 2024 Dec 26;19(12):e0316591. doi: 10.1371/journal.pone.0316591 |
| SSID | ssj0053866 |
| Score | 2.4399254 |
| Snippet | Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD- box RNA... Background Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD-... BackgroundBreast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD-... Background Breast cancer (BC) is the most often diagnosed cancer in women globally. Cancer cells appear to rely heavily on RNA helicases. DDX43 is one of DEAD-... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0284455 |
| SubjectTerms | Analysis Antigens Benign Biology and Life Sciences Biomarkers Biomarkers, Tumor - analysis Biomarkers, Tumor - genetics Blood cancer Breast cancer Breast Neoplasms - genetics Breast Neoplasms - pathology Cancer therapies Care and treatment DEAD-box RNA Helicases - genetics DEAD-box RNA Helicases - metabolism Disease Progression DNA helicase Domestic relations Electron tubes Enzyme-linked immunosorbent assay Female Females Gene expression Genes Genetic aspects Humans Invasiveness Medical prognosis Medicine and Health Sciences Messenger RNA Neoplasm Proteins - genetics Polymerase chain reaction Prognosis Proteins Real time RNA helicase RNA, Messenger - genetics Sample size Scientific equipment and supplies industry Serum levels Skin cancer Statistical analysis Time measurement Tumors |
| SummonAdditionalLinks | – databaseName: Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK8FBhiEBDxkS2PHH4-FMQ0khjQY6ltkxw5MKknVpNL-_N0lTtSgSeOBtyq-VO397s538vl3hLwx0jmZaRs7n7mYG2Vik1gTM8Zgf7GQYFs80f16Jk4v-JdlttwZ9YU9YT09cK-4I20Yt8IJbgTjTpW2KN280F57xQ3UIhh9E50MxVQfg8GLhQgX5ZicHwVcDtd15Q9hR-Ucr_btbEQdX_8YlWfrVd3clHL-3Tm5sxWd3Cf3Qg5JF_1v3yN3fPWA7AUvbei7QCX9_iFxx8dLzuif87MF9Veh57WipnK0I2i4rOgKu4YaCp82oS-OtjXtL0zWOK94iI40jPemdUkttrK3tECT2TwiFyeffnw8jcNchbgQmrVQLQpkbfeQrUmtRMYs10Y7iYdqaVZKiMUCywzvFTxUNpUmTRR4KnNFNgccHpNZBZrcJ1RZ7n2hZeYgLbGZ1QCOSguJA7GYdSoibFByXgTScZx9scq7kzQJxUevsxyhyQM0EYnHt9Y96cYt8h8Qv1EWKbO7B2BIeTCk_DZDishLRD_v75-Ojp8vJAdlQF4kIvK6k0DajAr7cn6ZbdPkn7_9_Aeh7-cTobdBqKxBHYUJdyHgPyGQE8mDiSQ4fzFZ3kdbHbTS5ABhljJIuhJ4c7Dfm5dfjcv4pdhrV_l628kIKXD2fESe9OY-ahZnGiF_UETUxBEmqp-uVJe_O9ZyiP2aayae_g-wnpG7KWSb2MYxVwdk1m62_jlkh6190QWCa2MTY2E priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnwtY4BBSMBDtjZ2_PGAUMc2DSQKKgz1LbJjd0wqSWlaiT-fu8QJC5qAtyq-VMmd7yu--x0hz410Tqbaxs6nLuZGmdgMrYkZY-BfLATYFk90P0zE2Tl_P0tnW2TS9sJgWWVrE2tD7cocv5EfJgo8DQNvMnyz_BHj1Cg8XW1HaJgwWsG9riHGbpBtMMnpcEC2j04mn6atbQbtFiI00DE5OgzyOliWhT8AT8s5tvxdcVA1jn9nrQfLRVldF4r-WVF5xUWd3ia3QmxJx81m2CFbvrhDdoL2VvRlgJh-dZe44-MZZ_T7dDKm_meohS2oKRytgRsuC7rAaqKKwq9VqJej65I2jZQlzjFurSYNY79pOacWS9zXNMettLpHzk9Pvrw9i8O8hTgXmq0hixSI5u4hipNaiZRZro12Eg_bknQuwUYLTD-8V3BR2USaZKhAg5nL05ER7D4ZFMDJXUKV5d7nWqYOwhWbWj13kMjkEgdlMetURFjL5CwPYOQ4E2OR1SdsEpKShmcZiiYLoolI3N21bMA4_kF_hPLraBFKu75Qri6yoJmZNoxb4QSHF-BOzW0Oz5prr73iBpLdiDxB6WdNX2pnELKx5MAMiJdERJ7VFAinUWC9zoXZVFX27uPX_yD6PO0RvQhE8xLYkZvQIwHvhILsUe73KMEo5L3lXdyrLVeq7Lf6wJ3t_r1--Wm3jH-KNXiFLzc1jZACZ9JH5EGz3TvO4qwjxBWKiOopQo_1_ZXi8luNZg4-QXPNxN7fn-shuZlAfImFGyO1Twbr1cY_gnhwbR8HJf8FDSBgZg priority: 102 providerName: ProQuest |
| Title | DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37200388 https://www.proquest.com/docview/2815236610 https://www.proquest.com/docview/2816765452 https://pubmed.ncbi.nlm.nih.gov/PMC10194936 https://doaj.org/article/9a34b6d64a634d8fbcfd1c9e9e84a717 http://dx.doi.org/10.1371/journal.pone.0284455 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1db9Mw0Nq6F14Q42uBUQxCAh5StbFjJw8IdR9lIFFQoahvkR27Y1JJStNK499z5zoRQUXsJaric9rc9_XOd4S8UNIYGac6NDY2IVeJClVfq5AxBvZFg4OtMaP7cSwupvzDLJ7tkXpmq0dgtTO0w3lS09Wid_3z11sQ-DduaoMc1Jt6y7KwPbCXnMfxPjlwGSMs5uNNXgGk22Uv0WsJRdRn_jDdv57SMlaup3-juTvLRVntckv_rq78w1yN7pDb3s-kwy1jHJI9W9wlh16SK_rKt5t-fY-Ys7MZZ_THZDyk9trXxRZUFYa6Jg5XBV1gZVFF4dPK187RdUm3hypLnGlca1DqR4DTck41lruvaY5stbpPpqPzr6cXoZ-9EOYiZWuIKAV2drfg0ck0ETHTPFWpkZh4i-K5BH0tMBSxNoGbiY6kivoJSDMzeTxQgj0gnQIweURoorm1eSpjA66LjnU6NxDU5BKHZjFtkoCwGslZ7huT43yMReaybRIClC3OMiRN5kkTkLDZtdw25vgP_AnSr4HFttruRrm6zLyUZqliXAsjOLwAN8lc5_Bb89SmNuEKAt-APEXqZ9szqo1yyIaSAzLAdxIBee4gsLVGgbU7l2pTVdn7T99uAPRl0gJ66YHmJaAjV_68BLwTErIFedyCBAWRt5aPkFdrrFQZkDCOGDhmfdhZ8-_u5WfNMj4U6_EKW24cjJAC59MH5OGW3RvM4twj7DEUkKQlCC3Ut1eKq--usznYh5SnTDy6wRc_JrcicDixkmOQHJPOerWxT8BBXOsu2ZczCdfkdIDX0bsuOTg5H3-edN1fLl2nE34D1WBoyQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAviPG1wmAGgYCHbG3sOM7DhDq6aWVbQWVDfQt27I5JJSlNK-Cf42_jLnHCgibgZW9RfImSu_Pdz_Z9EPJMhcaEQaQ9YwPjcSWVpzpaeYwx8C8aALbGE93joTg45W_HwXiF_KxyYTCssrKJhaE2WYJ75Nu-BE_DwJt0Xs--etg1Ck9XqxYayrVWMDtFiTGX2HFof3yDJVy-M-iDvJ_7_v7eyZsDz3UZ8BIRsQWsnQTWMLeAXcJIioBpHqnIhHjE5AeTECyTQNBtrYSbUvuh8jsS9JaZJOgqweC918gqxw2UFlnd3Ru-H1W-AKyJEC5hj4XdbacfW7MstVvg2TnHFMMLDrHoG1B7h9ZsmuWXQd8_IzgvuMT9W-Smw7K0VyrfGlmx6W2y5qxFTl-6ktav7hDT7485o19Gwx61313sbUpVamhRKOI8pVOMXsopXM1dfB5dZLRM3Mywb3JlpalrM06zCdUYUr-gCaru_C45vRLO3yOtFDi5TqjU3NokCgMD8EgHOpoYWDglITbmYtrINmEVk-PEFT_HHhzTuDjRC2ERVPIsRtHETjRt4tVPzcriH_-g30X51bRYuru4kc3PYmcJ4kgxroURHH6AGznRCXxrEtnISq5gcd0mmyj9uMyDrQ1Q3As5MAPwmWiTpwUFlu9IMT7oTC3zPB68-_gfRB9GDaIXjmiSATsS5XIy4J9QkA3KjQYlGKGkMbyOulpxJY9_T1d4stLfy4ef1MP4Uoz5S222LGhEKADh-21yv1T3mrPYWwnrGLWJbEyEBuubI-n556J6OvigiEdMPPj7d22S6wcnx0fx0WB4-JDc8AHbYtBIV26Q1mK-tI8Aiy70YzfhKfl01TbmF0aPml8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJyFeEONrgcEMAgEPWdvYsZOHCXV01cqgTIOhvgU7dsakkpSmFfAv8ldxlzplQRPwsrcqvkTJ3fl3d_V9EPJESWNkGGvf2ND4XEXKVx2tfMYY2BcNDrbGE923I3Fwwl-Pw_Ea-VnXwmBaZY2JFVCbIsX_yNtBBJaGgTXptDOXFnHUH7ycfvVxghSetNbjNJQbs2B2q3Zjrsjj0P74BuFcuTvsg-yfBsFg_8OrA99NHPBTEbM5xFEC-5lb8GNkHImQaR6r2Eg8bgrCTAJKCXTArY3gYqQDqYJOBDrMTBp2lWDw3CtkXYLVh0BwfW9_dHRc2wVAFiFc8R6T3bbTlZ1pkdsdsPKcY7nhOeNYzRBYWYrWdFKUF7nBf2ZznjOPgxvkuvNraW-piBtkzeY3yYZDjpI-d-2tX9wipt8fc0a_HI961H53ebg5VbmhVdOIs5xOMJOppPBr5nL16LygyyLOAmco14hN3chxWmRUY3r9nKaoxrPb5ORSOH-HtHLg5CahkebWprEMDbhKOtRxZiCISiUO6WLaRB5hNZOT1DVCx3kck6Q63ZMQEC15lqBoEicaj_iru6bLRiD_oN9D-a1osY13daGYnSYOFZJYMa6FERw-gJso0ym8axrb2EZcQaDtkW2UfrKsiV2BUdKTHJgBvprwyOOKAlt55LgpTtWiLJPhu4__QfT-uEH0zBFlBbAjVa4-A74JBdmg3GpQAiCljeVN1NWaK2Xye-vCnbX-Xrz8aLWMD8X8v9wWi4pGSAHefuCRu0t1X3EW5yxhTyOPRI2N0GB9cyU_-1x1Ugd7FPOYiXt_f69tchWwJnkzHB3eJ9cCcHMxf6QbbZHWfLawD8AtneuHbr9T8umyIeYX9eeeow |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DDX43+mRNA+expression+and+protein+levels+in+relation+to+clinicopathological+profile+of+breast+cancer&rft.jtitle=PloS+one&rft.au=Amer%2C+Noha+N&rft.au=Khairat%2C+Rabab&rft.au=Hammad%2C+Amal+M&rft.au=Kamel%2C+Mahmoud+M&rft.date=2023-05-18&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=18&rft.issue=5&rft.spage=e0284455&rft_id=info:doi/10.1371%2Fjournal.pone.0284455&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |